Jun 18, 2026 08:32AM
May 14, 2026 08:35AM
Feb 4, 2026 08:47AM
Jan 30, 2026 06:08AM
Jul 22, 2025 08:40AM
Jul 2, 2025 06:40AM
Jun 26, 2025 08:08AM GRI Bio's (GRI) GRI-0621 Demonstrates Encouraging Safety Results at Planned Interim 6-Week Analysis in Ongoing Phase 2a Study in Idiopathic Pulmonary Fibrosis
Jun 11, 2025 06:39AM
May 22, 2025 08:03AM
May 15, 2025 08:35AM
May 8, 2025 08:48AM
Apr 14, 2025 06:55AM
Apr 1, 2025 11:15AM
Apr 1, 2025 09:00AM GRI Bio, Inc (GRI) Reports Encouraging Interim 2-Week Safety Results from Ongoing Phase 2a Study of GRI-0621
Mar 31, 2025 08:03AM
Mar 11, 2025 08:35AM
Feb 19, 2025 04:05PM
Feb 11, 2025 04:29PM
Nov 21, 2024 08:45AM
Nov 14, 2024 04:40PM
Oct 24, 2024 08:34AM GRI Bio, Inc (GRI) Raises a Total of $13.9M in Gross Proceeds Since the Beginning of 2024
Oct 16, 2024 08:45AM
Oct 8, 2024 06:17AM
Sep 30, 2024 08:30AM
Sep 26, 2024 08:01AM
Jul 8, 2024 09:05AM
Jul 2, 2024 09:06AM
Jun 27, 2024 09:00AM GRI Bio, Inc (GRI) Announces Korea Patent Granted for Proprietary Natural Killer T Cell Modulators
Jun 27, 2024 08:00AM
Jun 14, 2024 08:05AM
Jun 12, 2024 04:15PM

404,878 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All